LeadDiscovery - Therapeutic Advances - Focus on targeted Cancer Therapy

Saturday November 07 2009 | Biotechnology feed | All feeds

Return to introduction on drug discovery ~ LeadDiscovery Reports

TherapeuticAdvances - Focus on targeted Cancer Therapy

Metastatic control by histone deacetylase inhibitors
Cathepsin-D: A novel approach to breast cancer
Radioligand therapy: Targeting tumors with labeled lanreotide
Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy.
Survivin a candidate for cancer-specific apoptotic- and immuno-therapies
Camel antibody fragments for improved cancer immunotherapy
Trastuzumab as a treatment for lung cancer?
Specific activation of chemotherapeutic prodrugs in the tumor milieu
Immunotherapeutic targeting of P-glycoprotein
Virosome technology drives forward the fight against cancer
Improvement to immunotherapy made possible through modified ricin toxin

Projects such as these are overviewed in full DiscoveryDossiers.

Interested in the production and circulation of a DiscoveryDossier on your research, technology or products?

Therapeutic Advances is updated daily - please click the links below:

Introduction to Daily Update

Pain/Neurology

Metabolic disorders

Cardiovascular

Immunology & Inflammation

Cancer/Oncology

DiscoveryDossiers ~ TherapeuticsAdvances ~ PharmaceuticalSolutions ~ LeadDiscovery ~ Purchase DiscoveryDossiers ~

Post Events
Post Jobs
Post Company Profile
Post a Video
Post Product Information
Post a Press Release
Advertising
Search

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.